IP Library Granted Patent US 11,813,368
Granted Patent B2
US 11,813,368 · App. 17/896,902 · Granted Nov 14, 2023

Anti-microbial blue light systems and methods

Inventors: Robert A. Rabiner (Dortmund, DE); Liane J. Rabiner (Dortmund, DE); Gene P. DiPoto (Upton, MA); Anthony W. O'Leary (Walpole, MA); Michael P. Mogul (San Diego, CA)
Assignee: ABL Medical Inc.
A61L2/0052A61L2/084A61L2/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,813,368
App. No.
17/896,902
Granted
Nov 14, 2023
Kind
B2
Abstract

Systems, devices and methods for controlled intramedullary delivery of light (frequencies from about 380 nm to about 500 nm) to treat tissue or bones disorders, including osteomyelitis, by a flexible fiber are provided, where the light is delivered in a circumferential fashion around the fiber, and where the energy delivered from the fiber is of a similar average intensity at the front end and back end of the fiber, and in between. The methods and systems deliver intramedullary light to the canal over long lengths via a minimally invasive pathway to a bone. The methods and systems deliver and maintain a light delivery system within the canal of the bone to provide single or multiple doses of light to kill, eliminate, remove or reduce bacteria, viruses, fungus and pathogens, without removal of the light fiber system, thereby providing single or multiple treatments.

Claims (27)

1. A method for treating tissue, comprising:

delivering a catheter to a tissue;

delivering one or more optical fibers through the catheter to the tissue;

activating a light source engaging the one or more optical fibers; and

delivering light energy from the light source to the one or more optical fibers to provide an antimicrobial effect to the tissue, the one or more optical fibers dispersing the light energy such that intensity of the light energy is distributed evenly over a length of the one or more optical fibers in both longitudinal and circumferential directions.

2. The method of claim 1 , wherein the light source comprises a plurality of frequencies of the light energy.

3. The method of claim 2 , further comprising selecting one or more of the plurality of frequencies of light energy to activate based on the antimicrobial effect on specific microbial targets.

4. The method of claim 1 , wherein the light energy has illumination wavelengths from about 400 nm to about 475 nm.

5. The method of claim 1 , wherein the one or more optical fibers include a cladding covering an outer surface thereof, and wherein at least a portion of the cladding of the one or more optical fibers is removed from an outer surface of the one or more optical fibers to achieve the even dispersion of the light energy.

6. The method of claim 5 , wherein the at least a portion of the cladding is removed to form a helical spiral along the length of the one or more optical fibers.

7. The method of claim 1 , wherein the one or more optical fibers disperses the light energy evenly over an active length of the one or more optical fibers.

8. A method for treating tissue, comprising:

delivering a catheter to a tissue;

delivering one or more optical fibers through the catheter to the tissue;

selecting a power for a light source engaging the one or more optical fibers;

activating the light source engaging the one or more optical fibers; and

delivering light energy from the light source to the one or more optical fibers to provide an antimicrobial effect to the tissue, the one or more optical fibers dispersing the light energy such that intensity of the light energy is distributed evenly over a length of the one or more optical fibers with an even power distribution over the length of the one or more optical fibers based on the selected power.

9. The method of claim 8 , wherein the light energy is evenly dispersed over the length of the one or more optical fibers in both longitudinal and circumferential directions.

10. The method of claim 8 , wherein the light source comprises a plurality of frequencies of the light energy.

11. The method of claim 10 , further comprising selecting one or more of the plurality of frequencies of light energy to activate based on the antimicrobial effect on specific microbial targets.

12. The method of claim 8 , wherein the light energy has illumination wavelengths from about 400 nm to about 475 nm.

13. The method of claim 8 , wherein the one or more optical fibers disperses the light energy evenly over an active length of the one or more optical fibers.

14. A method for treating tissue, comprising:

delivering a catheter to a tissue;

delivering one or more optical fibers through the catheter to the tissue;

activating a light source engaging the one or more optical fibers; and

delivering light energy from the light source to the one or more optical fibers to provide an antimicrobial effect to the tissue, the one or more optical fibers dispersing the light energy such that power of the light energy is distributed evenly over a length of the one or more optical fibers in both longitudinal and circumferential directions.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2023
From: ILLUMINOSS MEDICAL, INC.
To: ABL MEDICAL INC.
Reel/Frame 064342/0209 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2023
From: RABINER, ROBERT A.; RABINER, LIANE J.; DIPOTO, GENE P.; O'LEARY, ANTHONY W.; MOGUL, MICHAEL P.
To: ILLUMINOSS MEDICAL, INC.
Reel/Frame 062311/0939 →
Continuity (3)
Provisional Application 63264174 · Nov 17, 2021
Provisional Application 63238104 · Aug 27, 2021
Related Publication 20230077399A1 · Mar 16, 2023